Hot or Die
See My Plan
Close-up of a couple embracing on a bed, showcasing love and intimacy.

Why Did My Sex Drive Drop in Perimenopause?

Why did my sex drive drop in perimenopause?

Reviewed by Taylor Anderson, RN

Aesthetic Registered Nurse

Taylor Anderson is an aesthetic registered nurse and a reviewer for Get Hot or Die.

Updated September 6, 2026

Quick answer

Sexual function often holds steady until late perimenopause, then desire, arousal and comfort decline together. Estrogen alone seldom restores desire, while testosterone helped distressing low desire in trials but was not shown to help energy, thinking or bone health.

In this guide

Key takeaways

  • Desire tends to fall and pain with sex tends to rise by late perimenopause; vaginal dryness and relationship status also track with sexual function.
  • Group patterns describe averages from self-reports and do not predict your personal timing or cause.
  • Transdermal testosterone brought more acne and hair growth with no rise in serious events during the trials, but no testosterone product is FDA-approved for women in the US because long-term safety data are still lacking.

Your sex drive likely fell in late perimenopause because hormone shifts affect arousal, vaginal comfort, and pain with sex. Long-term tracking shows sexual function often stays steady until about 20 months before the final period, then declines through the first year after for reasons that dryness or mood alone do not explain.

When and why does desire change in perimenopause?

In follow-up from seven US sites, women reported lower desire and more pain with sex by late perimenopause, even after researchers accounted for age, health, and mood. Vaginal dryness and relationship status also tracked with sexual function SWAN six-year results.

Longer tracking found clear timing. Sexual function, meaning desire, arousal, comfort, and satisfaction, held steady until about 20 months before the final period, fell year by year through the first year after, then continued to fall more slowly. Vaginal dryness, depressive symptoms, and anxiety did not explain that fall SWAN 14.5-year timing analysis. These studies describe group patterns from self-reports. They do not predict your timing or prove cause for every woman.

Will estrogen bring my libido back?

Estrogen alone seldom restores desire. A combined analysis of 34 trials found estrogen, estrogen plus progestogen, tibolone, and drugs that act like estrogen in some tissues gave no to small benefit on overall sexual function scores in perimenopausal and postmenopausal women hormone therapy meta-analysis.

So low desire often needs more than estrogen alone, even when estrogen helps other menopause symptoms.

What if low desire is distressing — what helps?

Doctors call persistent low desire that distresses you HSDD. In a combined look at seven trials in postmenopausal women with HSDD, those using transdermal testosterone reported more satisfying sexual episodes, stronger desire, more orgasms, and less distress than those using placebo. More users had acne and hair growth, with no rise in serious events during the trials transdermal testosterone meta-analysis.

A 2025 review describes that benefit as modest and for carefully selected postmenopausal women with HSDD. It notes no FDA-approved testosterone product for women in the United States because long-term safety data are still lacking, and current data do not support testosterone for energy, thinking, bone, or brain health 2025 testosterone review. In a UK clinic group of women already using HRT who added testosterone cream or gel, 52% said libido improved after 4 months UK menopause clinic cohort. That clinic record had no placebo group, so it shows what happened in that clinic, not what will happen for you.

If distressing low desire is your main symptom, take the quiz to check HOD plan fit for your history and goals.

Ready to make a move?

Answer three questions to see the options, prices, and providers that fit your goals.

See My Plan

FAQ

When does sex drive usually change in perimenopause?

Sexual function held steady until about 20 months before the final period, then fell year by year through the first year after and continued to fall more slowly. These are group averages from self-reports and do not predict individual timing.

Will estrogen alone bring desire back?

Estrogen alone seldom restores desire. Across trials, estrogen and related hormone options gave no to small benefit on overall sexual function scores, even when estrogen helped other menopause symptoms.

What helps if low desire is distressing?

Clinicians call persistent, distressing low desire HSDD. In trials in postmenopausal women with HSDD, transdermal testosterone was linked with more satisfying sexual episodes, stronger desire, more orgasms and less distress than placebo, with more acne and hair growth and no rise in serious events during the trials. Benefit is described as modest for carefully selected women, and no testosterone product is FDA-approved for women in the US because long-term safety data are still lacking.

Do vaginal dryness or mood explain the drop?

Not fully. In longer tracking, vaginal dryness, depressive symptoms and anxiety did not explain the decline in sexual function, although dryness and relationship status tracked with sexual function and pain with sex increased by late perimenopause.

Keep reading

Sources (20)
  1. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  2. Hormone therapy for sexual function in perimenopausal and... : Menopause · journals.lww.com · captured September 6, 2026
  3. Perimenopause and Sex Drive: Why It Changes & What Helps · vivevehealth.com · captured September 6, 2026
  4. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  5. Testosterone for the Treatment of Hypoactive Sexual Desire Disorder in Perimenopausal and Postmenopausal Women. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  6. Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  7. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  8. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women - ScienceDirect · sciencedirect.com · captured September 6, 2026
  9. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  10. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  11. Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  12. The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN). · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  13. Gynecologic & Sexual Health During the Menopause Transition | SWAN - Study of Women’s Health Across the Nation · swanstudy.org · captured September 6, 2026
  14. Navigating Physical Health & Function in Menopause · swanstudy.org · captured September 6, 2026
  15. Changes in kidney function during the menopausal transition: the Study of Women's Health Across the Nation (SWAN) - Michigan site. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  16. Fact Sheets | SWAN - Study of Women’s Health Across the Nation · swanstudy.org · captured September 6, 2026
  17. Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN). · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  18. Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation. · pubmed.ncbi.nlm.nih.gov · captured September 6, 2026
  19. Navigating Cognitive Decline for Women in Midlife | SWAN - Study of Women’s Health Across the Nation · swanstudy.org · captured September 6, 2026
  20. Depression Menopause | SWAN - Study of Women’s Health Across the Nation · swanstudy.org · captured September 6, 2026